These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22644004)

  • 1. Expected value of foveal thickness in macular edema in Mexican patients with diabetes.
    Lima-Gómez V; Razo Blanco-Hernández DM
    Cir Cir; 2012; 80(2):109-14. PubMed ID: 22644004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparity between foveal thickness and macular volume in diabetic macular edema.
    Lima-Gómez V; Blanco-Hernández DM
    Cir Cir; 2012; 80(1):25-30. PubMed ID: 22472149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for progression of subclinical diabetic macular oedema.
    Bhavsar KV; Subramanian ML
    Br J Ophthalmol; 2011 May; 95(5):671-4. PubMed ID: 21071757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of photocoagulation on center point thickness in diabetic macular edema.
    Lima-Gómez V; Razo Blanco-Hernández DM; Asbun-Bojalil J
    Cir Cir; 2011; 79(5):395-401. PubMed ID: 22385758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema.
    Kang SW; Park CY; Ham DI
    Am J Ophthalmol; 2004 Feb; 137(2):313-22. PubMed ID: 14962423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal thickness study with optical coherence tomography in patients with diabetes.
    Sánchez-Tocino H; Alvarez-Vidal A; Maldonado MJ; Moreno-Montañés J; García-Layana A
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1588-94. PubMed ID: 11980878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thickness.
    Campbell RJ; Coupland SG; Buhrmann RR; Kertes PJ
    Arch Ophthalmol; 2007 May; 125(5):619-23. PubMed ID: 17502499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
    Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B
    Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
    Browning DJ; Fraser CM; Clark S
    Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
    Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
    Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
    Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum lipids with macular thickness and volume in type 2 diabetes without diabetic macular edema.
    Sasaki M; Kawashima M; Kawasaki R; Uchida A; Koto T; Shinoda H; Tsubota K; Wang JJ; Ozawa Y
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1749-53. PubMed ID: 24569581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axial length measurement in eyes with diabetic macular edema: a-scan ultrasound versus IOLMaster.
    Attas-Fox L; Zadok D; Gerber Y; Morad Y; Eting E; Benamou N; Pras E; Segal O; Avni I; Barkana Y
    Ophthalmology; 2007 Aug; 114(8):1499-504. PubMed ID: 17331581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
    Nunes S; Ribeiro L; Lobo C; Cunha-Vaz J
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4595-604. PubMed ID: 23745006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.
    Simonazzi B; Balaskas K; Guex-Crosier Y
    BMC Ophthalmol; 2016 May; 16(1):59. PubMed ID: 27188332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subclinical diabetic macular edema and mild non-proliferative diabetic retinopathy: data correlation with the retinal thickness analyzer (RTA)].
    Ramalho LH; Avila MP; Moraes Júnior HV; Damasceno Ede F
    Arq Bras Oftalmol; 2009; 72(4):503-8. PubMed ID: 19820790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
    Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
    Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between macular microcirculation and progression of diabetic macular edema.
    Sakata K; Funatsu H; Harino S; Noma H; Hori S
    Ophthalmology; 2006 Aug; 113(8):1385-91. PubMed ID: 16877077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.